Clinical Trial

In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer

Study acronym: FAPI_VULVA_1
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 4, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate the expression of FAP by phosphor imaging in invasive vulvar squamous cell carcinoma specimens. This in vitro study will include all consecutive tumour specimens stored both in optimal cutting temperature (OCT) compound and formalin-fixed paraffin-embedded (FFPE) from patients with a first diagnosis of vulvar squamous cell carcinoma who underwent surgery at Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Trial Details
NCT Number NCT06911801
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Vulvar Squamous Cell Carcinoma
Enrollment 90 participants
Start Date 2025-04
Primary Completion 2026-01 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-04-04